We are live on ! Find out more
AMCA

Arthur M. Cohen & Associates Portfolio holdings

AUM $563M
1-Year Est. Return 20.97%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+20.97%
3 Year Est. Return
+97.14%
5 Year Est. Return
+130.41%
10 Year Est. Return
AUM
$292M
AUM Growth
+$12.1M
Cap. Flow
-$12.5M
Cap. Flow %
-4.26%
Top 10 Hldgs %
58.59%
Holding
120
New
7
Increased
34
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$1.14M
2
PGR icon
Progressive
PGR
+$1.1M
3
RTX icon
RTX Corp
RTX
+$448K
4
BLK icon
Blackrock
BLK
+$360K
5
ISRG icon
Intuitive Surgical
ISRG
+$317K

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Financials 18.95%
3 Technology 12.54%
4 Consumer Discretionary 7.76%
5 Consumer Staples 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$1.98M 0.68%
10,233
-1,765
-15% -$322K
VGT icon
27
Vanguard Information Technology ETF
VGT
$148B
$1.97M 0.67%
74,680
VOO icon
28
Vanguard S&P 500 ETF
VOO
$1.01T
$1.6M 0.55%
5,930
EW icon
29
Edwards Lifesciences
EW
$51.5B
$1.52M 0.52%
24,738
+1,020
+4% +$61.7K
LMT icon
30
Lockheed Martin
LMT
$135B
$1.45M 0.49%
3,980
+1
+0% +$335
PEP icon
31
PepsiCo
PEP
$189B
$1.43M 0.49%
10,933
-920
-8% -$118K
MDY icon
32
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$1.41M 0.48%
3,962
-75
-2% -$26.2K
CRM icon
33
Salesforce
CRM
$157B
$1.38M 0.47%
9,066
WBA
34
DELISTED
Walgreens Boots Alliance
WBA
$1.38M 0.47%
25,167
ACGL icon
35
Arch Capital
ACGL
$33.9B
$1.37M 0.47%
36,829
-200
-0.5% -$6.82K
TMO icon
36
Thermo Fisher Scientific
TMO
$216B
$1.28M 0.44%
4,334
+130
+3% +$35.8K
SDY icon
37
State Street SPDR S&P Dividend ETF
SDY
$23.9B
$1.28M 0.44%
12,696
+73
+0.6% +$7.3K
UL icon
38
Unilever
UL
$136B
$1.24M 0.42%
17,716
-3,725
-17% -$253K
PGR icon
39
Progressive
PGR
$125B
$1.13M 0.39%
+14,175
New +$1.1M
MKL icon
40
Markel Group
MKL
$23.2B
$1.13M 0.39%
1,036
-37
-3% -$38.8K
UNH icon
41
UnitedHealth
UNH
$370B
$1.06M 0.36%
4,363
IJR icon
42
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.06M 0.36%
13,576
-4,998
-27% -$388K
IJJ icon
43
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.97B
$1.01M 0.35%
12,708
-634
-5% -$50.3K
WMT icon
44
Walmart Inc
WMT
$887B
$1.01M 0.35%
27,492
-150
-0.5% -$5.17K
SBUX icon
45
Starbucks
SBUX
$121B
$970K 0.33%
11,569
VTWV icon
46
Vanguard Russell 2000 Value ETF
VTWV
$1.31B
$946K 0.32%
8,981
+272
+3% +$28.6K
DVY icon
47
iShares Select Dividend ETF
DVY
$23.6B
$941K 0.32%
9,455
+530
+6% +$52.3K
MCD icon
48
McDonald's
MCD
$195B
$925K 0.32%
4,455
+295
+7% +$58.4K
VHT icon
49
Vanguard Health Care ETF
VHT
$18.5B
$913K 0.31%
5,251
MDLZ icon
50
Mondelez International
MDLZ
$80.1B
$903K 0.31%
16,748

Similar funds

Arthur M. Cohen & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Arthur M. Cohen & Associates held 120 positions worth $292M, up 4.3% from $280M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Arthur M. Cohen & Associates withdrew a net $12.5M in Q2 2019, closing 4 positions and reducing 45 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $513K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Arthur M. Cohen & Associates opened a new position in iShares Russell 1000 ETF worth $399K.

  • Arthur M. Cohen & Associates's largest Q2 2019 buy was iShares Russell 1000 ETF: 7,134 shares worth $399K.
  • Arthur M. Cohen & Associates added most to RTX Corp in Q2 2019, an estimated $448K increase.
  • Arthur M. Cohen & Associates's biggest Q2 2019 reduction was Amgen, cutting an estimated $6.88M.
  • Arthur M. Cohen & Associates fully exited Agios Pharmaceuticals in Q2 2019, selling an estimated $513K.
  • Arthur M. Cohen & Associates's ten largest holdings make up 59% of its $292M portfolio in Q2 2019.
  • Arthur M. Cohen & Associates opened 7 new positions and closed 4 in Q2 2019.
  • Arthur M. Cohen & Associates's portfolio value rose 4.3% quarter-over-quarter to $292M.

Based on Arthur M. Cohen & Associates's 13F filing for Q2 2019, filed 29 Jul 2019.